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Abstract
Background: Hereditary spherocytosis is a genetic, frequently familial hemolytic blood disease characterized by
varying degrees of hemolytic anemia, splenomegaly, and jaundice. There are few reports on adult open-heart
surgery for patients with hereditary spherocytosis.
Case presentation: We report a rare case of an adult open-heart surgery associated with hereditary spherocytosis.
A 63-year-old man was admitted for congestive heart failure due to bicuspid aortic valve, aortic valve regurgitation,
and sinus of subaortic aneurysm. The family history, the microscopic findings of the blood smear, and the
characteristic osmotic fragility confirmed the diagnosis of hereditary spherocytosis. Furthermore, splenectomy had
not been undertaken preoperatively.
The patient underwent a successful operation by means of a centrifugal pump. Haptoglobin was used during the
cardiopulmonary bypass, and a biological valve was selected to prevent hemolysis. No significant hemolysis
occurred intraoperatively or postoperatively.
Conclusion: There are no previous reports of patients with hereditary spherocytosis, and bicuspid aortic valve. We
have successfully performed an adult open-heart surgery using a centrifugal pump in an adult patient suffering
from hereditary spherocytosis and bicuspid aortic valve.
Keywords: Hereditary spherocytosis, Adult cardiac, Bicuspid aortic valve, Cardiopulmonary bypass, Haptoglobin,
Centrifugal pump
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Background
Hereditary spherocytosis (HS) is a genetic, frequently
familial hemolytic blood disease characterized by varying
degrees of hemolytic anemia, splenomegaly, and jaundice.
The disease is associated with various defects in any of
the number of the proteins responsible for maintaining
the shape and flexibility of the red blood cell (RBC),
resulting in osmotically fragile and characteristically
spherical RBCs. Cardiopulmonary bypass (CPB) can ex-
acerbate hemolysis and subsequent renal dysfunction.
There are few reports on open-heart surgery for adult
patients with HS.
This study reports the case of a 63-year-old man with
HS who underwent aortic valve replacement, valval
aneurysm patch closure, and ascending aorta replacement.
Case presentation
The patient was a 63-year-old man with HS, idiopathic
aortic bileaflet, and subaortic aneurysm (SAA) caused by
infective endocarditis. The SAA was incidentally discov-
ered during a clinical evaluation for aortic regurgitation
(AR); this was due to idiopathic aortic bileaflet and in-
fective endocarditis that were diagnosed 10 years ago.
Because of the patient’s HS history and severe anemia, a
cardiologist conducted the medical follow-up. The pa-
tient’s LV systolic function worsened gradually and he
had frequent episodes of dyspnea. Moreover, transapical
echocardiography showed a decrease in the AR grading.
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On admission, the hemoglobin level was 8.7 mg/dL,
hematocrit was 23.8 %, platelet count was 18.2 × 104/μL,
blood urea nitrogen was 15.1 mg/dL, and creatinine was
0.93 mg/dL. The physical examination revealed an anemic
and icteric conjunctiva, and his skin appeared jaundiced.
The laboratory findings of the patient’s blood smear
revealed a type 1 + polychromasia.
The transthoracic echocardiogram showed a bicuspid
aortic valve (adhesions on the left and right coronary
cusps), a 10-mm SAA prolapsing at the atrio-ventricular
continuity, an ascending aorta measuring 38 mm, and a
grade IV central AR (Fig. 1). The left ventricular ejection
fraction was preserved. The computer tomography angi-
ography revealed a right coronary sinus aneurysm in the
sagittal and axial plane.
A surgical intervention was indicated because of severe
AR due to the bicuspid aortic valve, moderate dilation of
ascending aorta, and SAA. The procedure was performed
through a median sternotomy. A CPB was instituted by
ascending aortic cannulation and bicaval drainage. Left
atrial venting was carried out from the right upper pul-
monary vein. Cardioplegia was performed by selective
antegrade and retrograde perfusion with blood Frem’s
solution and cold blood. Before initiating the CPB, we
transfused four units of RBCs (hemoglobin of 12.1 mg/dL).
Furthermore, human haptoglobin was also transfused.
At the time of the CPB, the centrifuge pump was se-
lected rather than the roller pump, and perfusion index
was 2.5 L/m2/min. First, the epicardial membrane was
used for the repair of the SAA (Figs. 2 and 3). Second,
aortic valve replacement was performed by using the
biological valve (Magna EASE 21 mm, Carpentier-
Edwards, Japan). Third, an ascending aorta replacement
was performed under moderate hypothermia and cross-
clamping condition. The aortic cross-clamp time was
182 min, and CPB time was 234 min. The urine
remained clear throughout and after CPB, indicating
that no significant hemolysis had occurred during the
procedure. The patient was extubated on day 1, and all
the vasoactive infusions were discontinued on day 3
postoperatively.
Despite the 1.5 L RBC transfusion during the oper-
ation, the immediate postoperative blood smear did not
show any spherocytes and other abnormal RBC morph-
ologies. Postoperative bleeding was minimal, and fur-
ther RBC transfusions were performed on day 4 and 14
postoperatively.
The echocardiography showed no residual AR, and the
patient was discharged from the hospital on day 18 with-
out any hemolysis. At the 6-month follow-up, he was
doing well. Recent echocardiography showed no residual
AR, and good left ventricular function. Hematogenic
investigation showed the hemoglobin level to be main-
tained at 10.6 g/dL without any transfusion. The total bili-
rubin and lactate dehydrogenase levels were 3.9 mg/dL,
and 303 IU/L, respectively (Table 1).
Discussion
Hereditary spherocytosis, an autosomal dominant or re-
cessive trait most commonly (though not exclusively)
found in the Northern European and Japanese families,
affects one in 2000 individuals [1].
There are few publications about the HS management
during an open-heart surgery and there were no reports
of patients with HS, bicuspid aortic valve, and SAA. A
variety of approaches have been proposed for HS pa-
tients to avoid hemolysis during surgery. These include
cardiac surgery without CPB, preemptive splenectomy
Fig. 1 Subaortic aneurysm showed by TTE
Matsuzaki et al. Journal of Cardiothoracic Surgery  (2016) 11:138 Page 2 of 4
[2], administration of haptoglobin to reduce plasma-free
hemoglobin [3, 4], use of poloxamer 188 (a non-ionic
antihemolytic detergent that protects RBC membrane
during CPB) [5], or simply proceeding with surgery
employing CPB without any special measures [5–7]. No
significant hemolysis or renal failure has been reported
in these instances and no trial has compared these vari-
ous approaches.
It must be noted that in Japan, poloxamer 188 is not
permitted for use on humans; therefore, we did not con-
sider this when analyzing our case.
Although splenectomy is the only treatment for HS,
we did not proceed because this patient had the high op-
erative risk and he did not present with splenomegaly.
Our patient had multiple risks contraindicating cardiac
surgery; he had a bicuspid aortic valve and an enlarged
ascending aorta, which necessitated a valve change. In
addition, he had SAA and his HB level was low
(8.7 mg/dL); thus, a straightforward procedure was not
possible. For all these reasons and for the clinical safety of
the patient, we had to consider other alternatives. To re-
duce the risk of hemolysis during operation, we had four
measures as follows.
First, RBC (HB of 10 mg/dL) transfusion was performed
preoperatively. Second, aortic valve replacement was per-
formed by using a biological valve, probably less hemolysis
than mechanical valve. Third, we administered haptoglo-
bin. Because haptoglobin can link to the free hemoglobin
and change the complex form, this link can help the hep-
atic metabolism and prevent renal damage. In this case,
although haptoglobin was transfused during and after the
operation, haptoglobin level remained low. This could
Fig. 2 Subaortic aneurysm
Fig. 3 Repair of the Subaortic aneurysm (SAA)
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be explain by the fact that the speed of hemolysis for
an HS patient is high, implying that the patient requires
substantial amount of haptoglobin. Finally, we used a
centrifugal pump because the risk of hemolysis is less
with a centrifugal pump rather than with a roller pump
[8]. The hematology-related approach, the improve-
ment in surgical techniques, and the CPB technology
will certainly reduce the complications associated with
surgical intervention in patients with HS.
Conclusion
The outcome in this case was good as evidenced by the
no residual AR, lack of hemolysis, and the preserved
splenic function. We can conclude that we have success-
fully performed an adult open-heart surgery by using a
centrifugal pump in a patient suffering from HS and
bicuspid aortic valve.
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Table 1 Changes in the laboratory data
Before
operation
Ope Day 3 Day 10 Day 18 6 months
RBC (106/μL)) 243 339 265 276 362 295
Hb (g/dl) 8.7 10.5 7.9 8.2 11 10.6
Hct (%) 23.8 29.8 24.7 25.1 32.9 28.7
T.B. (mg/dL) 3.3 9.8 6.6 1.6 2 3.9
LDH (IU/L) 141 265 380 262 302 303
Haptoglobin 24 <10 <10 <10 <10 22
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